@article{van Dijk_Nurmohamed_Hooning van Duijvenbode_Veltman_Rentenaar_Weinans_Vogely_van der Wal_2022, title={A mean 4-year evaluation of infection control rates of hip and knee prosthetic joint infection-related revision arthroplasty: an observational study}, volume={93}, url={https://actaorthop.org/actao/article/view/3975}, DOI={10.2340/17453674.2022.3975}, abstractNote={<p><strong>Background and purpose:</strong> The long-term results of the 1- or 2-stage revision procedure and infection-free prosthesis survival in a tertiary referral center are unknown. In this retrospective observational study, the long-term results of infection control and infection-free prosthesis survival of the periprosthetic joint infection-related 1- and 2-stage revision procedure are evaluated. Furthermore, the merits of performing an antibiotic-free window in the 2-stage revision is evaluated.<br /><strong>Patients and methods:</strong> All patients who received a 1- or 2-stage revision procedure of the hip or knee between 2010 and 2017 were included. Data was collected on patient and infection characteristics. The primary treatment aim was successful infection control without the use of antibiotic therapy afterwards. Infection-free survival analysis was performed using the Kaplan–Meier method with type of periprosthetic joint infection-related revision as covariate. Within the group of 2-stage revisions, use of an antibioticfree window was selected as covariate.<br /><strong>Results:</strong> 128 patients were treated for a periprosthetic joint infection-related revision procedure (81 hips and 47 knees). Successful infection control was achieved in 18 of 21 cases for the 1-stage and 89 out of 107 cases for the 2-stage revision procedure (83%) respectively after follow-up of more than 4 years. In addition, 2-stage revision procedure infection control was achieved in 52 of 60 cases with an antibiotic-free interval and 37 of 45 cases without such interval (p = 0.6). The mean infection-free survival of the 1-stage<br />revision was 90 months (95% CI 75–105) and 98 months (CI 90–106) for the 2-stage revision procedure.<br /><strong>Interpretation:</strong> There seems to be no difference in infection control and infection-free survival between the 1- and 2-stage revision procedure. Second, an antibiotic-free window in the case of a 2-stage revision did not seem to influence treatment outcome. However, one must be cautious when interpreting these results due to confounding by indication and the small study population. Therefore, no definite conclusion can be drawn.</p>}, journal={Acta Orthopaedica}, author={van Dijk, Bruce and Nurmohamed, F Ruben H A and Hooning van Duijvenbode, J Fred F and Veltman, Ewout S and Rentenaar, Rob J and Weinans, Harrie and Vogely, H Charles and van der Wal, Bart C H}, year={2022}, month={Jul.}, pages={652–657} }